BPC-157 in Australia: Regulatory Status and Research Context

Also known as: Body Protection Compound 157

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic peptide that has been the subject of preclinical research internationally. It consists of 15 amino acids and is derived from a protein found in human gastric juice. BPC-157 is not currently listed on the Australian Register of Therapeutic Goods (ARTG) for routine prescribing and remains an investigational substance under international study. This page provides general information about BPC-157's research and regulatory context and is not medical advice.

Regulatory Status in Australia

BPC-157 is not currently TGA-approved for routine prescribing in Australia. It is not listed on the ARTG for any indication. Under Australian law, unapproved therapeutic goods may only be accessed through limited regulatory pathways including the TGA's Special Access Scheme (SAS), Authorised Prescriber Scheme, or approved clinical trials. Each pathway requires involvement of an AHPRA-registered medical practitioner and has specific eligibility criteria and regulatory oversight. Compounding pharmacies may supply BPC-157 under valid prescribing frameworks where clinically appropriate.

Research Context

BPC-157 has been investigated in preclinical and animal studies, primarily conducted in laboratory settings. Published research has explored its effects in various experimental models. While some human case reports exist, large-scale randomised controlled trials in humans have not been published in peer-reviewed literature. The full safety and efficacy profile continues to be characterised. The research to date does not constitute approval for routine clinical use, and findings from preclinical studies cannot be directly extrapolated to human therapeutic outcomes.

What This Means for Australians

BPC-157 is an investigational substance not currently TGA-approved for routine prescribing
Access may be possible through limited pathways like the SAS, requiring an AHPRA-registered doctor
Anyone interested should discuss options with an AHPRA-registered medical practitioner
Clinics listed on Peptide Finder can be compared by treatment focus areas including injury recovery
Always speak with a qualified healthcare professional before starting any new treatment program

This page provides general information only and is not medical advice. Always speak with a qualified healthcare professional before starting any new medical treatment. Any prescribing decision is made by the treating practitioner after an individual clinical assessment.

Compare Clinics

34 clinics offering related consultations. Compare details, then contact the clinic that looks like the best fit.

Peptide Finder is a clinic directory only. We do not prescribe, supply, or advertise prescription medicines. Suitability is determined by the prescribing doctor at consultation.

Elite

GL Vitality Drips

Sydney, NSW

4.9(32)

Director-led, Australia-wide telehealth service connecting clients with AHPRA-registered doctors and licensed compounding pharmacies. Medical oversight is provided by Dr. Harrison Weisinger (Dr. Harry), an Australian family doctor with a PhD in preventative and evidence-based healthcare. Founded by Gemma - clients liaise directly with her throughout their program.

Injury RecoveryWeight ManagementMuscle & PerformancePlus more

Aus-wide delivery